iShares JPMorgan USD Emerging Markets Bond ETF vs Herbalife Nutrition Ltd — how do they compare? iShares JPMorgan USD Emerging Markets Bond ETF trades at $91.59 (market cap $12.87B), while Herbalife Nutrition Ltd trades at $12.8 (market cap $1.34B). The key difference: iShares JPMorgan USD Emerging Markets Bond ETF is far larger — about 9.6× Herbalife Nutrition Ltd's market cap, and Herbalife Nutrition Ltd is trading nearer its 52-week high, iShares JPMorgan USD Emerging Markets Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares JPMorgan USD Emerging Markets Bond ETF for 50 Days and Herbalife Nutrition Ltd for 43 Days on average.
| EMB | HLF | |
|---|---|---|
Market Cap | $12.87B | $1.34B |
Volume | 14,946,002 | 1,589,457 |
Sector | Fixed Income | Consumer Staples |
52-Week High | $97.74 | $19.96 |
52-Week Low | $90.14 | $7.75 |
Typical Hold Time | 50 Days | 43 Days |
Enterprise Value | — | $3.18B |
Signals from Pluang's Aura AI — not financial advice
EMB trades at $90.78, down 0.19% with a bearish technical signal from moving averages. The stock shows neutral oscillator readings with RSI at oversold levels. Recent dividend declarations of $0.41-$0.44 per share provide income support, though key valuation ratios remain unavailable for analysis. Technical indicators suggest the stock is testing support levels near $90-$91.
The outlook remains cautious given the bearish technical momentum and limited fundamental data visibility. Income investors may find value in the dividend yield, but the lack of current financial metrics and bearish technical signals suggest near-term pressure. Market sentiment appears mixed with fixed income ETFs seeing inflows while emerging market bonds face AI-driven yield pressures.
Herbalife (HLF) trades at $12.65, up 0.56% with a bullish technical signal supported by moving averages. The company shows solid fundamentals with a low P/E of 8.11 and P/S of 0.26, though recent earnings have been mixed with two misses and one beat. A $250 million share repurchase program and CEO transition in October 2026 highlight ongoing corporate developments. Cash flow trends show improvement with projected positive net cash flow of $50 million in 2026.
HLF presents a value opportunity with discounted valuation metrics and analyst consensus target of $19.00 (50% upside). However, risks include negative shareholder equity, high debt levels, and inconsistent earnings performance. The stock offers potential for investors comfortable with turnaround execution risks in the wellness sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
EMB invests in U.S. dollar-denominated sovereign debt from emerging market countries. It provides exposure to government bonds from dozens of nations like Turkey, Mexico, and Brazil, offering a way to seek higher yields and geographic diversification.
Read more on EMB →Herbalife Nutrition Ltd is an international nutrition company.
Read more on HLF →